ONCOSIL MEDICAL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.007 AUD | 0.00% |
|
+16.67% | -22.22% |
| Jun. 11 | OncoSil Medical Treats Fifth Pancreatic Cancer Patient with Proprietary Device | MT |
| Jun. 03 | Oncosil Medical Treats 200th Pancreatic Cancer Patient with Proprietary Device | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCOSIL MEDICAL LIMITED | Other Pharmaceuticals | 0.00% | +16.67% | -22.22% | -41.67% | -86.27% | 16.16M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- OSL Stock
- Charts OncoSil Medical Limited
- Comparison Chart
